Cinvanti Injection, Emulsion
Product Images NDC 47426-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cinvanti (NDC 47426-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heron Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of The Chemical Structure (Cinvanti 01)

Chemical structure diagram of aprepitant, the active ingredient in CINVANTI injection emulsion. The structure shows multiple fluorine atoms and their specific stereochemistry as labeled (R) and (S).*

FDA Label Image

Image Of Carton (Principle Panel)

Label for CINVANTI injection, an aprepitant injectable emulsion with a strength of 130 mg/18 mL (7.2 mg/mL) for intravenous use. The single-dose vial must be refrigerated at 2°C to 8°C (36°F to 46°F) and not frozen; unused portions should be discarded. Manufactured by Heron Therapeutics.*

FDA Label Image

Image Of Carton (Principle Panel)

CINVANTI (aprepitant) injectable emulsion 130 mg/18 mL (7.2 mg/mL) label for intravenous use only. The label states storage requirements: refrigerate at 2°C-8°C (36°F-46°F) and do not freeze. It also notes this is a sterile single-dose vial and instructs to discard unused portion. Labeler is Heron Therapeutics, Inc., and the product is marked Not For Sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.